Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

KRX-0401 studied with Revlimid and dexamethasone for multiple myeloma

Jan. 2, 2007

Bioenvision prepares MAA for Evoltra in AML

Jan. 2, 2007

KSP inhibitor ARRY-520 to begin clinical testing

Jan. 2, 2007

Sunitinib filed in Japan for renal carcinoma and gastrointestinal stromal tumors

Jan. 2, 2007

ThromboGenics and BioInvent receive funding for antiangiogenesis program

Jan. 2, 2007

CoFactor and 5-FU studied in refractory metastatic breast cancer

Jan. 2, 2007

Zadaxin plus DTIC improves survival in stage IV malignant melanoma

Jan. 2, 2007

Oncolytics Biotech begins new Reolysin studies

Jan. 2, 2007

ABT-737 sensitizes AML cells to Flt3 inhibitor

Jan. 2, 2007

Preliminary findings from three Telcyta phase III studies

Dec. 29, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...